The FDA awarded 17 first-time premarket approvals in the first half of 2014, up from nine PMAs granted in the first half of last year. If the trend continues there will be 34 PMAs this year. The swiftest PMA review was for Medtronic’s transcatheter aortic valve CoreValve with a turnaround time of just 5.8 months.
More articles on devices:
Aesculap Implant Systems releases new spinal system
Osseon receives FDA clearance, launches steerable balloon product
Medtronic spine revenue continues downward spiral — but is there light at the end of the tunnel? 8 1Q takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
